1. Long-term follow-up and risk of cancer death after radiation for post-prostatectomy rising prostate-specific antigen;Swanson GP;Int J Radiat Oncol Biol Phys,2011
2. Parker CC, Clarke NW, Cook AD, Kynaston HG, Petersen PM, Catton C, et al. Timing of radiotherapy after radical prostatectomy (RADICALS-RT): a randomised, controlled phase 3 trial. Lancet. 2020 Oct 31;396(10260):1413–1421. doi: 10.1016/S0140-6736(20)31553-1. Epub 2020 Sep 28. PMID: 33002429.
3. Kneebone A, Fraser-Browne C, Duchesne GM, Fisher R, Frydenberg M, Herschtal A, et al. Adjuvant radiotherapy versus early salvage radiotherapy following radical prostatectomy (TROG 08.03/ANZUP RAVES): a randomised, controlled, phase 3, non-inferiority trial. Lancet Oncol. 2020 Oct;21(10):1331–1340. doi: 10.1016/S1470-2045(20)30456-3. PMID: 33002437.
4. Sargos P, Chabaud S, Latorzeff I, Magné N, Benyoucef A, Supiot S, et al. Adjuvant radiotherapy versus early salvage radiotherapy plus short-term androgen deprivation therapy in men with localised prostate cancer after radical prostatectomy (GETUG-AFU 17): a randomised, phase 3 trial. Lancet Oncol. 2020 Oct;21(10):1341–1352. doi: 10.1016/S1470-2045(20)30454-X. PMID: 33002438.
5. Radiation with or without Antiandrogen Therapy in Recurrent Prostate Cancer;Shipley WU;N Engl J Med,2017